Chris Lai

Company: Metis Pharmaceuticals

Job title: Chief Executive Officer and Co-Founder

Seminars:

Panel Discussion: The Diary of an LNP Biotech CEO: From Concept to Clinic 9:15 am

 Revealing the steps taken to transition from stealth to established to develop LNPs at a biotechnology company  Outlining the priority action points collectively as an industry to drive progress in 2024 Discussing interactions with regulatory bodies and the early planning steps taken in anticipation of future submissionsRead more

day: Conference Day Two - AM

Advancing AI and ML to Develop World-First LNPs for Muscle Cell Targeting via Intravenous Administration 4:45 pm

Pioneering the use of AI and ML in the development of LNPs designed for precision extra-hepatic targeting. Unveiling novel LNPs with capability to target skeletal and cardiac muscle cells following intravenous administration, without using active targeting moieties. Presenting in vivo transfection data in various murine models, demonstrating precise muscle cell transfection and liver detargeting.Read more

day: Conference Day One - PM

Rethinking How to Enter Partnerships & Appear Attractive to Large Pharma 2:00 pm

Effectively translating company status and current goals to large pharma for future collaborations Highlighting the key qualities of ‘partnerable’ companies Translating clearly what large pharma can gain from the partnership in the short term and long termRead more

day: Post-Conference Day